BGN Mutations in X-Linked Spondyloepimetaphyseal Dysplasia

Am J Hum Genet. 2016 Jun 2;98(6):1243-1248. doi: 10.1016/j.ajhg.2016.04.004. Epub 2016 May 26.

Abstract

Spondyloepimetaphyseal dysplasias (SEMDs) comprise a heterogeneous group of autosomal-dominant and autosomal-recessive disorders. An apparent X-linked recessive (XLR) form of SEMD in a single Italian family was previously reported. We have been able to restudy this family together with a second family from Korea by segregating a severe SEMD in an X-linked pattern. Exome sequencing showed missense mutations in BGN c.439A>G (p.Lys147Glu) in the Korean family and c.776G>T (p.Gly259Val) in the Italian family; the c.439A>G (p.Lys147Glu) mutation was also identified in a further simplex SEMD case from India. Biglycan is an extracellular matrix proteoglycan that can bind transforming growth factor beta (TGF-β) and thus regulate its free concentration. In 3-dimensional simulation, both altered residues localized to the concave arc of leucine-rich repeat domains of biglycan that interact with TGF-β. The observation of recurrent BGN mutations in XLR SEMD individuals from different ethnic backgrounds allows us to define "XLR SEMD, BGN type" as a nosologic entity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Amino Acid Sequence
  • Biglycan / chemistry
  • Biglycan / genetics*
  • Biglycan / metabolism
  • Child
  • Child, Preschool
  • Female
  • Genetic Diseases, X-Linked / genetics*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Osteochondrodysplasias / genetics*
  • Pedigree
  • Protein Binding
  • Protein Conformation
  • Sequence Homology, Amino Acid
  • Transforming Growth Factor beta / chemistry
  • Transforming Growth Factor beta / genetics
  • Transforming Growth Factor beta / metabolism

Substances

  • BGN protein, human
  • Biglycan
  • Transforming Growth Factor beta

Supplementary concepts

  • Spondyloepimetaphyseal Dysplasia, X-Linked